4//SEC Filing
LAWRENCE DAVID 4
Accession 0001209191-18-061106
CIK 0001008848other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 8:22 AM ET
Size
5.0 KB
Accession
0001209191-18-061106
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-12-03$20.55/sh−2,493$51,232→ 3,653 total
Footnotes (2)
- [F1]Sales pursuant to a 10b5-1 plan.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.0900 to $20.8000 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
ACORDA THERAPEUTICS INC
CIK 0001008848
Entity typeother
Related Parties
1- filerCIK 0001272353
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 8:22 AM ET
- Size
- 5.0 KB